Welcome to this week’s issue of China Briefing’s Belt & Road Initiative Weekly Investor Intelligence round up.
As COVID-19 vaccines start to come to market, we look at the two different types of vaccines that are being developed, their pros and cons, and where across Asia distribution will commence and when.
We provide details of 40 countries in Asia and their plans for domestic COVID-19 vaccination distribution.
China’s COVID-19 vaccines are expected to be rolled out soon; bulk manufactured and exported in 2021. China could likely mass inoculate citizens in any outbreak that crosses a certain threshold; the country is expected to develop herd immunity over longer term. The Sinovac vaccine (in limited roll-out) costs RMB 400.
Details of COVID-19 vaccine development in all 10 ASEAN countries.